home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

CEO of Novozymes, the world’s largest industrial biotechnology company, comments on Paris climate agreement


Paris, France
December 12, 2015

“After decades of extremely complicated negotiations Paris proved to be the historic turning point in international efforts to tackle the evident dangers posed by climate change. This sends a very strong signal to businesses, investors and markets: Low-carbon technologies will advance, and we need to reduce our use of fossil fuels such as coal and oil.

“Business cannot succeed in a world that fails; with the Paris agreement global politicians have finally signaled intent to move our planet towards a low-carbon future. Our politicians have shown courage to reach this agreement – now we must all be courageous to ensure that the enabling technologies behind low-carbon solutions are taken forward.

“It will of course take some time for everyone to fully digest all the implications of Paris – even for a business like Novozymes that has been engaged with climate issues for many years.

But the signals are clear: Political intent to move the world towards a low-carbon future, and backing for the private sector’s crucial role in tackling climate change to see opportunities in, and establish solutions to enable, a low-carbon world.

“There is a clear opportunity for business to partner and drive innovative low-carbon and energy efficient solutions forward, which will fit very well with the DNA of Novozymes – a company that is all about using biological innovation to allow for more efficient industrial processes, using less chemicals, less water, less energy.

Implementation of the agreement is now crucial – and that is where we will spend a lot of our efforts going forward. It is up to world’s countries to move forward with their national action plans, where they can select or deselect specific industries and sectors for investment and innovation. We will follow those processes closely. Countries will be on a five-year review cycle, which will – hopefully – support ever-lower emission reductions.

Novozymes congratulates those who have worked hard to negotiate this unprecedented agreement, which also has seen an unprecedented recognition of the contribution from the business community to which Novozymes and many members of staff, including myself, have been engaged.

“Novozymes has a net-positive carbon impact across all industries and LCA modeling of CO2 reductions. As for specific industries and countries with the most potential on the backdrop of this historic agreement that is currently too early to tell. Again, the national action plans are going to be crucial to now follow – and support.

“We are witnessing a shift in terms of the role of businesses: A realization is now kicking in that climate change represents opportunities, not only costs. We develop solutions to the world’s most pressing problems, we profit from doing so – and invest in solving more problems. That is basically our business model – and more and more companies are starting to realize this approach.”

Quick facts

  • Last year, Novozymes’ biological solutions – notably in industrial processes such as agriculture, bioenergy and consumer products such as detergents – helped reduce its customers’ emissions by 60 million tons of CO2. That is equivalent to taking 25 million cars off the road.
  • By 2020, Novozymes is committed to save the world 100 million tons of CO2 emissions a year through customers applying its products, while also reaching six billion people with biological products. Novozymes has also promised to deliver 10 transformative innovations that really change the lives of many people and fulfill ambitious sustainability goals.

Novozymes position on climate change

About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet’s resources and helping build better lives. As the world’s largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. 



More news from: Novonesis


Website: https://www.novonesis.com/en

Published: December 13, 2015

The news item on this page is copyright by the organization where it originated
Fair use notice

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

  Archive of the news section

 

 


Copyright @ 1992-2024 SeedQuest - All rights reserved